Related Experiment Video
Updated: Mar 13, 2026
08:24
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
7.5K
Current therapy of acute heart failure.
1Lehrstuhl Innere Medizin III, Medizinische Universitätsklinik, Homburg/Saar, FRG.
Cardiovascular Drugs and Therapy
|October 11, 2016
Summary
Acute heart failure management focuses on treating underlying causes and stabilizing hemodynamics. Amrinone is highlighted for improving cardiac output without increasing myocardial oxygen demand, unlike dobutamine.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute heart failure stems from reduced myocardial contractility (e.g., myocardial infarction, cardiomyopathy, post-surgery).
- Mechanical defects like septal rupture require surgical intervention.
- Systemic hemodynamics can be supported by mechanical circulatory assist devices.
Purpose of the Study:
- To outline therapeutic strategies for acute heart failure.
- To compare the efficacy and safety of pharmacological agents, specifically amrinone and dobutamine.
Main Methods:
- Medical therapy aims to relieve pulmonary congestion and ensure systemic perfusion.
- Pharmacological approaches are tailored to individual hemodynamic profiles.
- Agents with combined vasodilatory and inotropic effects are utilized.
Main Results:
- Both dobutamine and amrinone improve cardiac pump performance.
- Amrinone offers an advantage by not increasing myocardial oxygen consumption.
- Amrinone demonstrates less tolerance development and arrhythmogenicity compared to dobutamine.
Conclusions:
- Therapy for acute heart failure should address causal factors and hemodynamic status.
- Amrinone presents a favorable option for improving cardiac output in acute heart failure.
- Careful patient monitoring and selection of appropriate pharmacological agents are crucial.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.5K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
11.1K
Related Concept Videos
01:30Heart Failure V: Medical Management
459
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
459
01:22Heart Failure VI: Adjunct Therapies
497
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
497
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
01:22Heart Failure Drugs: β-Blockers
1.1K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:30Heart Failure VII: Nursing Interventions
639
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
639